Literature DB >> 9600484

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

J Danesh1, R Collins, P Appleby, R Peto.   

Abstract

CONTEXT: A large number of epidemiologic studies have reported on associations between various "inflammatory" factors and coronary heart disease (CHD).
OBJECTIVE: To assess the associations of blood levels of fibrinogen, C-reactive protein (CRP), and albumin and leukocyte count with the subsequent risk of CHD. DATA SOURCES: Meta-analyses of any long-term prospective studies of CHD published before 1998 on any of these 4 factors. Studies were identified by MEDLINE searches, scanning of relevant reference lists, hand searching of cardiology, epidemiology, and other relevant journals, and discussions with authors of relevant reports. STUDY SELECTION: All relevant studies identified were included. DATA EXTRACTION: The following information was abstracted from published reports (supplemented, in several cases, by the authors): size and type of cohort, mean age, mean duration of follow-up, assay methods, degree of adjustment for confounders, and relationship of CHD risk to the baseline assay results. DATA SYNTHESIS: For fibrinogen, with 4018 CHD cases in 18 studies, comparison of individuals in the top third with those in the bottom third of the baseline measurements yielded a combined risk ratio of 1.8 (95% confidence interval [CI], 1.6-2.0) associated with a difference in long-term usual mean fibrinogen levels of 2.9 pmol/L (0.1 g/dL) between the top and bottom thirds (10.3 vs 7.4 pmol/L [0.35 vs 0.25 g/dL]). For CRP, with 1053 CHD cases in 7 studies, the combined risk ratio of 1.7 (95% CI, 1.4-2.1) was associated with a difference of 1.4 mg/L (2.4 vs 1.0 mg/L). For albumin, with 3770 CHD cases in 8 studies, the combined risk ratio of 1.5 (95% CI, 1.3-1.7) was associated with a difference of 4 g/L (38 vs 42 g/L, ie, an inverse association). For leukocyte count, with 5337 CHD cases in the 7 largest studies, the combined risk ratio of 1.4 (95% CI, 1.3-1.5) was associated with a difference of 2.8 x 10(9)/L (8.4 vs 5.6 x 10(9)/L). Each of these overall results was highly significant (P<.0001).
CONCLUSIONS: The published results from these prospective studies are remarkably consistent for each factor, indicating moderate but highly statistically significant associations with CHD. Hence, even though mechanisms that might account for these associations are not clear, further study of the relevance of these factors to the causation of CHD is warranted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600484     DOI: 10.1001/jama.279.18.1477

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  450 in total

1.  Heart disease and the inflammatory response.

Authors:  W Koenig
Journal:  BMJ       Date:  2000-07-22

2.  Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults.

Authors:  David Q Rich; Howard M Kipen; Wei Huang; Guangfa Wang; Yuedan Wang; Ping Zhu; Pamela Ohman-Strickland; Min Hu; Claire Philipp; Scott R Diehl; Shou-En Lu; Jian Tong; Jicheng Gong; Duncan Thomas; Tong Zhu; Junfeng Jim Zhang
Journal:  JAMA       Date:  2012-05-16       Impact factor: 56.272

3.  Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.

Authors:  L Maria Belalcazar; Christie M Ballantyne; Wei Lang; Steven M Haffner; Julia Rushing; Dawn C Schwenke; F Xavier Pi-Sunyer; Russell P Tracy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-04-21       Impact factor: 8.311

4.  The Dietary Inflammatory Index is associated with elevated white blood cell counts in the National Health and Nutrition Examination Survey.

Authors:  Michael D Wirth; Maria Sevoyan; Lorne Hofseth; Nitin Shivappa; Thomas G Hurley; James R Hébert
Journal:  Brain Behav Immun       Date:  2017-12-05       Impact factor: 7.217

5.  C-Reactive Protein Gene Contributes to the Genetic Susceptibility of Hemorrhagic Stroke in Men: a Case-Control Study in Chinese Han Population.

Authors:  Yong Xue; Long Zhang; Yao Fan; Qianhui Li; Yuzhang Jiang; Chong Shen
Journal:  J Mol Neurosci       Date:  2017-07-18       Impact factor: 3.444

6.  Stroke seasonality associations with subtype, etiology and laboratory results in the Ludwigshafen Stroke Study (LuSSt).

Authors:  Frederick Palm; Michael Dos Santos; Christian Urbanek; Matthias Greulich; Kathrin Zimmer; Anton Safer; Armin Jürgen Grau; Heiko Becher
Journal:  Eur J Epidemiol       Date:  2013-02-06       Impact factor: 8.082

7.  The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial.

Authors:  Abdulhamied Alfaddagh; Tarec K Elajami; Mohamad Saleh; Mohamad Elajami; Bruce R Bistrian; Francine K Welty
Journal:  J Clin Lipidol       Date:  2018-03-14       Impact factor: 4.766

8.  Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

Authors:  H S Gurm; D L Bhatt; A M Lincoff; J E Tcheng; D J Kereiakes; N S Kleiman; G Jia; E J Topol
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

9.  Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation.

Authors:  Wendy M R van Herpen-Broekmans; Ineke A A Klöpping-Ketelaars; Michiel L Bots; Cornelis Kluft; Hans Princen; Henk F J Hendriks; Lilian B M Tijburg; Geert van Poppel; Alwine F M Kardinaal
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  Acute cardiovascular effects of firefighting and active cooling during rehabilitation.

Authors:  Jefferey L Burgess; Michael D Duncan; Chengcheng Hu; Sally R Littau; Delayne Caseman; Margaret Kurzius-Spencer; Grace Davis-Gorman; Paul F McDonagh
Journal:  J Occup Environ Med       Date:  2012-11       Impact factor: 2.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.